Essex Savings Bank’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $913K | Sell |
2,520
-36
| -1% | -$12.3K | 0.2% | 107 |
|
|
2026
Q1 | $899K | Buy |
2,556
+20
| +0.8% | +$7.13K | 0.2% | 104 |
|
|
2025
Q4 | $830K | Sell |
2,536
-864
| -25% | -$274K | 0.18% | 108 |
|
|
2025
Q3 | $959K | Sell |
3,400
-38
| -1% | -$11K | 0.22% | 93 |
|
|
2025
Q2 | $960K | Sell |
3,438
-754
| -18% | -$214K | 0.23% | 90 |
|
|
2025
Q1 | $1.31M | Sell |
4,192
-54
| -1% | -$15.9K | 0.32% | 71 |
|
|
2024
Q4 | $1.11M | Buy |
4,246
+27
| +0.6% | +$8.01K | 0.27% | 80 |
|
|
2024
Q3 | $1.36M | Buy |
4,219
+160
| +4% | +$52.3K | 0.34% | 68 |
|
|
2024
Q2 | $1.27M | Sell |
4,059
-334
| -8% | -$98.1K | 0.34% | 71 |
|
|
2024
Q1 | $1.27M | Hold |
4,393
| – | – | 0.37% | 63 |
|
|
2023
Q4 | $1.27M | Sell |
4,393
-189
| -4% | -$51.5K | 0.37% | 63 |
|
|
2023
Q3 | $1.23M | Buy |
4,582
+59
| +1% | +$14.7K | 0.42% | 56 |
|
|
2023
Q2 | $1M | Buy |
4,523
+160
| +4% | +$37.1K | 0.34% | 70 |
|
|
2023
Q1 | $1.05M | Sell |
4,363
-35
| -0.8% | -$8.59K | 0.37% | 64 |
|
|
2022
Q4 | $1.16M | Buy |
4,398
+280
| +7% | +$75.1K | 0.41% | 61 |
|
|
2022
Q3 | $928K | Buy |
4,118
+35
| +0.9% | +$8.48K | 0.37% | 68 |
|
|
2022
Q2 | $993K | Sell |
4,083
-110
| -3% | -$27K | 0.38% | 66 |
|
|
2022
Q1 | $1.01M | Buy |
4,193
+14
| +0.3% | +$3.22K | 0.34% | 74 |
|
|
2021
Q4 | $940K | Buy |
4,179
+68
| +2% | +$14.4K | 0.32% | 81 |
|
|
2021
Q3 | $927K | Sell |
4,111
-37
| -0.9% | -$8.52K | 0.34% | 83 |
|
|
2021
Q2 | $987K | Buy |
4,148
+149
| +4% | +$36.7K | 0.38% | 72 |
|
|
2021
Q1 | $899K | Buy |
3,999
+160
| +4% | +$38.2K | 0.39% | 68 |
|
|
2020
Q4 | $883K | Sell |
3,839
-60
| -2% | -$13.8K | 0.39% | 66 |
|
|
2020
Q3 | $991K | Buy |
3,899
+69
| +2% | +$17.1K | 0.49% | 54 |
|
|
2020
Q2 | $903K | Buy |
3,830
+46
| +1% | +$10.5K | 0.54% | 48 |
|
|
2020
Q1 | $767K | Sell |
3,784
-203
| -5% | -$44.3K | 0.55% | 49 |
|
|
2019
Q4 | $962K | Sell |
3,987
-175
| -4% | -$38.6K | 0.49% | 56 |
|
|
2019
Q3 | $805K | Sell |
4,162
-2,590
| -38% | -$497K | 0.43% | 60 |
|
|
2019
Q2 | $1.25M | Buy |
6,752
+3,606
| +115% | +$646K | 0.44% | 54 |
|
|
2019
Q1 | $598K | Buy |
3,146
+150
| +5% | +$28.6K | 0.34% | 68 |
|
|
2018
Q4 | $583K | Buy |
+2,996
| New | +$584K | 0.37% | 67 |
|
Other funds holding AMGN
Essex Savings Bank's AMGN Position: Q2 2026 in Review
Essex Savings Bank reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $12.3K and leaving 2,520 shares worth $913K. The position accounts for 0.2% of the portfolio, ranked #107.
Essex Savings Bank first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.36M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Essex Savings Bank held 2,520 shares of Amgen worth $913K as of Q2 2026.
- Essex Savings Bank sold 36 Amgen shares in Q2 2026, an estimated $12.3K.
- Amgen made up 0.2% of Essex Savings Bank's portfolio in Q2 2026, its #107 holding.
- Essex Savings Bank first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Essex Savings Bank's Amgen position peaked at $1.36M in Q3 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.